Related Experiment Video
Updated: May 1, 2026

08:22
Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
Published on: February 23, 2020
10.2K
System-on-fluidics immunoassay device integrating wireless radio-frequency-identification sensor chips.
Yoshiaki Yazawa1, Tadashi Oonishi1, Kazuki Watanabe1
1Hitachi, Ltd., Central Research Laboratory, 1-280 Higashi-koigakubo, Kokubunji, Tokyo 185-8601, Japan.
Journal of Bioscience and Bioengineering
|April 17, 2014
Summary
A new point-of-care-test (POCT) device uses chemiluminescence immunoassay and RFID sensors for sensitive detection. It features a two-stage temperature compensation system, improving precision for diagnostics like thyroid-stimulating hormone (TSH) testing.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Immunosensors
Background:
- Point-of-care-test (POCT) devices require high sensitivity and precision for accurate diagnostics.
- Chemiluminescence (CL) immunoassays offer sensitive detection but can be affected by environmental factors like temperature.
- Existing POCT devices often lack robust temperature compensation, impacting signal stability and reliability.
Purpose of the Study:
- To develop a simple and sensitive POCT device for CL immunoassay.
- To implement a novel two-stage temperature compensation scheme for enhanced precision.
- To evaluate the device's performance for thyroid-stimulating hormone (TSH) detection.
Main Methods:
- A POCT device integrating a flow-channel reactor with photo-sensor and temperature-sensor chips was designed.
- Radio-frequency-identification (RFID) technology enabled batteryless, wireless data communication.
- A two-stage temperature compensation strategy was employed, differentiating photodiode signals and utilizing temperature sensor data.
Main Results:
- The two-stage temperature compensation significantly reduced dark-level fluctuation from 0.24 to 0.02 pA/°C.
- The optimized CL immunoassay for TSH achieved a low detection limit of 0.08 ng/ml (0.4 μIU/ml).
- The developed POCT device demonstrated reliable and sensitive performance.
Conclusions:
- The novel POCT device offers a simple, sensitive, and precise platform for CL immunoassays.
- The integrated temperature compensation system effectively mitigates environmental variations, enhancing diagnostic accuracy.
- This technology holds promise for improved point-of-care diagnostics, particularly for hormone level monitoring.

